Clarity in cell line development

Join Solentim, along with leading European cell line development innovators, at Bioprocessing Summit Europe 2020

Bioprocessing Summit Europe 2020Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be exhibiting at the 3rd annual Bioprocessing Summit Europe, taking place 24-26 March 2020 in Barcelona.

European life science is thriving, with world-class research institutions and medical centres, and 16 of the world’s top 50 universities for life sciences[1]. Bioprocessing Summit Europe is the ideal place to access this growing network, with 82% of delegates attending from Europe and 80% of attendees working in the biotech and pharma sectors. The event brings together leading upstream, downstream and biomanufacturing scientists to share day-to-day challenges and practical solutions for today’s bioprocessing needs.

Attendees will hear from Gabriela Kozejova, Senior Scientist, GSK Medicines Research Centre, on “How to Be Good at Being Single? Evaluation of VIPS Single-Cell Printer for Generation of Stable Cell Lines,” at 11:15am on Thursday 26th March. In this presentation Gabriela will report the impact of implementing systems such as Solentim’s Verified In-situ Plate Seeding (VIPSTM) system linked with the Cell Metric imager, resulting in increased throughput, reduced timelines, and the provision of clonality assurance for stable cell-line processes.

Mark Truesdale, Chief Marketing Officer, Solentim, commented: “We are excited to reconnect with our European network during this event, and to form new links with the rapidly expanding European bioprocessing industry.”

Solentim will be onsite at booth #8 throughout the conference.

[1] https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/biotech-in-europe-a-strong-foundation-for-growth-and-innovation
Translate »